by Nadia N. Sawicki The D.C. Circuit’s recent decision vacating the FDA’s graphic labeling requirements has prompted a flood of valuable commentary about compelled speech doctrine, including Richard Epstein’s, below. While analysis of the First Amendment issues is important, I view the R.J. Reynolds case instead as an example of how emphasis on formal legal…
By The Petrie-Flom Center Jurimetrics: The Journal of Law, Science, and Technology (ASU/ABA) is seeking submissions for a special symposium issue edited by James Hodge on the Intersection of Law, Science, and Policy to Protect the Public’s Health, to be published in Spring 2013. Potential manuscripts may include: Examinations of how and why law, policy,…
By Michele Goodwin For all the attention by legal scholars, doctors, and politicians to the global organ shortage—and particularly the crisis in the United States, relatively little is said about tissue demand and that supply industry. Well known are the horrific stories involving black markets specializing in organs like kidneys and livers. The troubling stories…
By Holly Fernandez Lynch On November 2 at Harvard Law School, the Petrie-Flom Center and the Edmond J. Safra Center for Ethics will be co-sponsoring a day-long symposium organized by Dr. David Korn on institutional financial conflicts of interest in research universities. The speaker line-up is incredible, including Francis Collins, Derek Bok, and Zeke Emanuel, among other…
By Hyeongsu Park In May 2012, Health Canada granted market authorization for Prochymal. This decision is the world’s first regulatory approval of a stem cell drug (as well as the first therapy for acute graft-vs-host disease, a serious complication of bone marrow transplantation that kills up to 80% of children affected). Like Prochymal, many stem…
By Adriana Lee Benedict The 14th round of negotiations for the Trans-Pacific Partnership Agreement (TPPA, a multilateral trade agreement currently being negotiated by the USTR and 10 other countries) is currently underway in Leesburg, VA. Last month, KEI posted a brief video blog about an interesting provision (Article 8.2) of the TTPA’s leaked draft IP…
By Nicolas Terry Kathleen Boozang, The New Relators: In-House Counsel and Compliance Officers, SSRN David Asch & Kevin Volpp, What Business Are We In? The Emergence of Health as the Business of Health Care, NEJM Kate Greenwood, Carl Coleman, & Kathleen Boozang, Toward Evidence-Based Conflicts of Interest Training for Physician-Investigators, SSRN/JLME Barbara Noah, The Role…
By Scott Burris, JD Law has been used to protect and promote public health from the early days of European colonization of North America. Quarantine statutes and orders are reported from the mid-17th century. The 1793 yellow fever epidemic in Philadelphia, where our office is based, inspired the federal government’s first public health statute, authorizing…
